Regulatory Pathway

African mother and child in telemedicine consultation with a remote doctor

MEDTRAC™

Venture profile

Regulatory and quality pathways for MedTech deployment in sensitive health environments.

MEDTRAC™ is being developed through staged research, clinical testing, pilot preparation and community deployment. A planned FDA and CE regulatory and certification pathway is scheduled to begin in Q3 2027, subject to testing, validation and regulatory assessment.

Planned pathway (Q3 2027)

Q3 2027 — begin the planned FDA and CE process. This is a planned pathway, not a completed certification. Timing and scope remain subject to testing, validation, regulatory assessment and pilot results.

Staged evidence generation through Malta proving ground and African pilots
Clinical decision-support evaluation with practitioner oversight
Blinded laboratory confirmation where appropriate during field trials
Ethics, governance and data-protection arrangements ahead of wider deployment

Evidence and validation foundations

Regulatory readiness depends on demonstrating reliable data capture, usable offline operation, appropriate triage performance, practitioner acceptance and correlation with reference methods where applicable.

Reliable data capture and repeatable workflows
Usable offline operation under intermittent connectivity
Practitioner acceptance and quality of follow-up
Correlation with appropriate reference methods where applicable
Measurable improvements in access and continuity of care

Governance alongside regulation

Patient consent and privacy controls
Role-based access and audit trails
AI-assisted workflows reviewed by qualified professionals
Defined escalation pathways to clinics, laboratories and hospitals
Government-controlled use of population health data for ministry reporting